A majority of patients feel lay summaries for clinical trials are very important and won’t participate in future trials if not provided with one...
Featured content
A Summarized Report of the Virtual MedTech EU MDR Exchange...
Session summaries from EUMDR exchange conference 2021.
Latest Content
Understanding Patient Centricity, Progress Made, and Barriers...
Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their opinions on what patient centricity...
Medical Device Manufacturing: Risk-Based QMS Alignment for EU-MDR
The latest EU-MDR guidelines are a step in the right direction, moving from a focus on the pre-approval stage of medical device manufacturing toward...
What Makes Stakeholders Trust Pharma-Generated Scientific...
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the content itself is still largely designed...
Effectiveness of Artificial Intelligence–Powered Translation...
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical publication development...
Survey Report: Understanding Patient Centricity, Progress Made...
Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress that the industry has...
Ways Pharma Showed Patients How They Matter
Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how some pharma and biotech companies have...